Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4262]

SABCS 2011: Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive breast cancer

SABCS 2011: Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive...

SABCS 2011: Starch intake may influence risk for breast cancer recurrence

SABCS 2011: Starch intake may influence risk for breast cancer recurrence

SABCS 2011: MRI may be noninvasive method to measure breast cancer prognosis

SABCS 2011: MRI may be noninvasive method to measure breast cancer prognosis

SABCS 2011: Addition of trastuzumab may potentially equalise disease-free survival outcomes among obese and normal-weight patients

SABCS 2011: Addition of trastuzumab may potentially equalise disease-free survival outcomes among obese and normal...

SABCS 2011: Many women do not undergo breast reconstruction after mastectomy

SABCS 2011: Many women do not undergo breast reconstruction after mastectomy

SABCS 2011: Risk for developing new cancer in other breast increased for survivors with BRCA mutation

SABCS 2011: Risk for developing new cancer in other breast increased for survivors with BRCA mutation

SABCS 2011: Intermittent, low-carbohydrate diets more successful than standard dieting, present possible intervention for breast cancer prevention

SABCS 2011: Intermittent, low-carbohydrate diets more successful than standard dieting, present possible...

SABCS 2011: Brachytherapy associated with twofold increased risk for mastectomy complications

SABCS 2011: Brachytherapy associated with twofold increased risk for mastectomy complications

SABCS 2011: New test predicts risk for recurrence for patients with DCIS

SABCS 2011: New test predicts risk for recurrence for patients with DCIS

SABCS 2011: Exemestane plus everolimus increased progression-free survival for women with metastatic breast cancer

SABCS 2011: Exemestane plus everolimus increased progression-free survival for women with metastatic breast cancer

More from ecancer